世界のタンパク質治療市場2020-2024

◆英語タイトル:Global Protein Therapeutics Market 2020-2024
◆商品コード:IRTNTR43438
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年4月23日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートではタンパク質治療の世界市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別(mAbs、ヒトインスリン、エリスロポエチン、凝血因子、その他)分析、治療分野別(代謝・内分泌障害、造血、生殖能力、癌、その他)分析、タンパク質機能野別(酵素・調節活性、特掲活性、ワクチン、タンパク質診断)分析、顧客状況、地域別状況、企業状況、企業分析などを総合的、多面的に調査・分析しました。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・タンパク質治療の世界市場:製品別(mAbs、ヒトインスリン、エリスロポエチン、凝血因子、その他)
・タンパク質治療の世界市場:治療分野別(代謝・内分泌障害、造血、生殖能力、癌、その他)
・タンパク質治療の世界市場:タンパク質機能野別(酵素・調節活性、特掲活性、ワクチン、タンパク質診断)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Protein Therapeutics Market 2020-2024

Technavio has been monitoring the protein therapeutics market and it is poised to grow by $ 82.47 bn during 2020-2024 progressing at a CAGR of 7% during the forecast period. Our reports on protein therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increased demand for mAbs and the availability of favorable reimbursement policies.

The protein therapeutics market analysis includes product segment and geographic landscape.
Technavio’s protein therapeutics market is segmented as below:
By Product
• mAbs
• Human insulin
• Erythropoeitin
• Clotting factors
• Others

By Geographic Landscapes
• North America
• Europe
• APAC
• South America
• MEA

This study identifies the development of novel therapies using innovative technologies as one of the prime reasons driving the protein therapeutics market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our protein therapeutics market covers the following areas:
• Protein therapeutics market sizing
• Protein therapeutics market forecast
• Protein therapeutics market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading protein therapeutics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., Novo Nordisk AS, Pfizer Inc., and Sanofi. Also, the protein therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/global-protein-therapeutics-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o mAbs – Market size and forecast 2019-2024
o Human insulin – Market size and forecast 2019-2024
o Erythropoeitin – Market size and forecast 2019-2024
o Clotting factors – Market size and forecast 2019-2024
o Others – Market size and forecast 2019-2024
o Market opportunity by Product
• Market segmentation by Therapy Area
o Market segments
o Metabolic and endocrine disorders
o Hematopoiesis
o Fertility
o Cancer
o Autoimmune diseases
o Infectious diseases
o Protein vaccine
• Market segmentation by Protein Function
o Market segments
o Enzymatic and regulatory activity
o Special targeting activity
o Vaccines
o Protein diagnostics
• Customer Landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o South America – Market size and forecast 2019-2024
o MEA – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o AbbVie Inc.
o Amgen Inc.
o AstraZeneca Plc
o Eli Lilly and Co.
o F. Hoffmann-La Roche Ltd.
o Johnson & Johnson
o Merck & Co. Inc.
o Novo Nordisk AS
o Pfizer Inc.
o Sanofi
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ billion)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Product – Market share 2019-2024 (%)
• 22: Comparison by Product
• 23: mAbs – Market size and forecast 2019-2024 ($ billion)
• 24: mAbs – Year-over-year growth 2019-2024 (%)
• 25: Human insulin – Market size and forecast 2019-2024 ($ billion)
• 26: Human insulin – Year-over-year growth 2019-2024 (%)
• 27: Erythropoeitin – Market size and forecast 2019-2024 ($ billion)
• 28: Erythropoeitin – Year-over-year growth 2019-2024 (%)
• 29: Clotting factors – Market size and forecast 2019-2024 ($ billion)
• 30: Clotting factors – Year-over-year growth 2019-2024 (%)
• 31: Others – Market size and forecast 2019-2024 ($ billion)
• 32: Others – Year-over-year growth 2019-2024 (%)
• 33: Market opportunity by Product
• 34: Customer landscape
• 35: Market share by geography 2019-2024 (%)
• 36: Geographic comparison
• 37: North America – Market size and forecast 2019-2024 ($ billion)
• 38: North America – Year-over-year growth 2019-2024 (%)
• 39: Europe – Market size and forecast 2019-2024 ($ billion)
• 40: Europe – Year-over-year growth 2019-2024 (%)
• 41: APAC – Market size and forecast 2019-2024 ($ billion)
• 42: APAC – Year-over-year growth 2019-2024 (%)
• 43: South America – Market size and forecast 2019-2024 ($ billion)
• 44: South America – Year-over-year growth 2019-2024 (%)
• 45: MEA – Market size and forecast 2019-2024 ($ billion)
• 46: MEA – Year-over-year growth 2019-2024 (%)
• 47: Key leading countries
• 48: Market opportunity by geography ($ billion)
• 49: Impact of drivers and challenges
• 50: Vendor landscape
• 51: Landscape disruption
• 52: Industry risks
• 53: Vendors covered
• 54: Market positioning of vendors
• 55: AbbVie Inc. – Overview
• 56: AbbVie Inc. – Business segments
• 57: AbbVie Inc. – Key offerings
• 58: AbbVie Inc. – Key customers
• 59: AbbVie Inc. – Segment focus
• 60: Amgen Inc. – Overview
• 61: Amgen Inc. – Business segments
• 62: Amgen Inc. – Key offerings
• 63: Amgen Inc. – Key customers
• 64: Amgen Inc. – Segment focus
• 65: AstraZeneca Plc – Overview
• 66: AstraZeneca Plc – Business segments
• 67: AstraZeneca Plc – Key offerings
• 68: AstraZeneca Plc – Key customers
• 69: AstraZeneca Plc – Segment focus
• 70: Eli Lilly and Co. – Overview
• 71: Eli Lilly and Co. – Business segments
• 72: Eli Lilly and Co. – Key offerings
• 73: Eli Lilly and Co. – Key customers
• 74: Eli Lilly and Co. – Segment focus
• 75: F. Hoffmann-La Roche Ltd. – Overview
• 76: F. Hoffmann-La Roche Ltd. – Business segments
• 77: F. Hoffmann-La Roche Ltd. – Key offerings
• 78: F. Hoffmann-La Roche Ltd. – Key customers
• 79: F. Hoffmann-La Roche Ltd. – Segment focus
• 80: Johnson & Johnson – Overview
• 81: Johnson & Johnson – Business segments
• 82: Johnson & Johnson – Key offerings
• 83: Johnson & Johnson – Key customers
• 84: Johnson & Johnson – Segment focus
• 85: Merck & Co. Inc. – Overview
• 86: Merck & Co. Inc. – Business segments
• 87: Merck & Co. Inc. – Key offerings
• 88: Merck & Co. Inc. – Key customers
• 89: Merck & Co. Inc. – Segment focus
• 90: Novo Nordisk AS – Overview
• 91: Novo Nordisk AS – Business segments
• 92: Novo Nordisk AS – Key offerings
• 93: Novo Nordisk AS – Key customers
• 94: Novo Nordisk AS – Segment focus
• 95: Pfizer Inc. – Overview
• 96: Pfizer Inc. – Business segments
• 97: Pfizer Inc. – Key offerings
• 98: Pfizer Inc. – Key customers
• 99: Pfizer Inc. – Segment focus
• 100: Sanofi – Overview
• 101: Sanofi – Business segments
• 102: Sanofi – Key offerings
• 103: Sanofi – Key customers
• 104: Sanofi – Segment focus
• 105: Currency conversion rates for US$
• 106: Research Methodology
• 107: Validation techniques employed for market sizing
• 108: Information sources
• 109: List of abbreviations



【掲載企業】

AbbVie Inc., Amgen Inc., AstraZeneca Plc, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., Novo Nordisk AS, Pfizer Inc., Sanofi

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のタンパク質治療市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆